ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,179Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 559

$618K Total Retail Price of All Prescriptions

Rank: 17 out of 559

498 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 9,174 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 535 457 1 1
AMLODIPINE BESYLATE 398 348 2 6
SIMVASTATIN 396 345 3 3
LEVOTHYROXINE SODIUM 379 307 4 2
OMEPRAZOLE 321 220 5 4
FUROSEMIDE 311 285 6 11
HYDROCODONE-ACETAMINOPHEN 306 231 S3 7 7
POTASSIUM CHLORIDE 237 213 8 23
GABAPENTIN 232 166 9 9
METFORMIN HCL 230 179 10 5
LOVASTATIN 218 180 11 10
METOPROLOL TARTRATE 210 210 12 12
ATENOLOL 168 140 13 15
METOPROLOL SUCCINATE 148 139 14 16
WARFARIN SODIUM 140 134 15 24
TAMSULOSIN HCL 139 138 16 25
HYDROCHLOROTHIAZIDE 139 120 16 8
MELOXICAM 128 75 18 42
TRAMADOL HCL 118 105 19 27
OXYBUTYNIN CHLORIDE 109 91 20 62
ALENDRONATE SODIUM 107 91 21 13
DIOVAN 103 103 22 55
TRAZODONE HCL 101 96 23 28
ZOLPIDEM TARTRATE 101 70 23 17
CYMBALTA 98 68 25 78
ATORVASTATIN CALCIUM 98 88 25 20
LANTUS 94 84 27 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 76 27 18
NEXIUM 90 47 29 57
SERTRALINE HCL 88 88 30 19
DONEPEZIL HCL 87 87 31 36
ACTOS 85 59 32 87
JANUVIA 84 65 33 50
CRESTOR 83 55 34 33
CARVEDILOL 81 77 35 38
AZITHROMYCIN 77 61 36 39
NAMENDA 76 76 37 56
CLOPIDOGREL 73 51 38 51
ADVAIR DISKUS 72 66 39 46
SPIRONOLACTONE 70 69 40 74
GLIMEPIRIDE 67 66 41 53
PREDNISONE 66 59 42 49
BENAZEPRIL-HYDROCHLOROTHIAZIDE 65 54 43 147
PLAVIX 65 51 43 76
DIOVAN HCT 63 54 45 134
BENAZEPRIL HCL 61 44 46 85
RANITIDINE HCL 60 59 47 26
ISOSORBIDE MONONITRATE ER 59 55 48 120
NIFEDIPINE ER 57 57 49 139
TRICOR 56 19 50 142
CARISOPRODOL 53 12 R 51 73
PROAIR HFA 53 30 51 29
OXYCODONE-ACETAMINOPHEN 51 30 S2 53 44
HYDROXYZINE HCL 50 44 R 54 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.